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INTRODUCTION
Perhaps one of the greatest achievements in medicine 
to date, organ transplantation has transformed the lives of 
thousands – bringing life to those who would surely have died 
without it. This achievement is dependent upon a generous 
gift from another person. From one deceased donor up to 55 
lives may be saved or improved.1 With progressive advances 
in the trauma system, emergency physicians (EPs) are faced 
with more severely injured trauma patients, including the 
potentially brain-dead. The purpose of this three-part series 
is to present the components of determining brain death, to 
discuss the pathophysiology unique to brain-dead patients and 
to outline an algorithm based on that physiology to improve 
the care of the brain-dead patient. Rather than selectively 
neglect the brain-dead patient, active management while the 
patient is still in the emergency department (ED), specialty 
consultation and critical care can significantly enhance the 
likelihood of successful organ donation, turning a tragic loss 
into a rewarding patient encounter. 
The majority of transplanted organs come from brain-
dead or cadaveric donors. As most of these donors enter 
the healthcare system through the ED as either trauma 
patients with brain injuries or medical patients with acute 
intracranial hemorrhage, EPs are often involved in the 
diagnosis, referral, and initial stabilization of these patients. 
When these injuries would not benefit from neurosurgical or 
neurologic intervention and are deemed to be non-survivable, 
they are “devastating brain injuries.” The EP’s goal shifts to 
maintaining hemodynamic stability to diagnose brain death, 
should it occur. Furthermore, we must prepare the family 
for devastating news and allow them to begin the grieving 
process. EPs and trauma surgeons are often involved in 
discussions of end-of-life care and intensive care management 
of critical illness and injury. Therefore, both groups have the 
ability to impact organ donation, transplant frequency and 
success.
Table 1. Glasgow Coma Scale
Motor
6 Purposeful; follows commands
5 Localizes to pain
4 Withdraws to pain
3 Decorticate posture
2 Decerebrate posture
1 No movement
Verbal
5 Oriented
4 Confused
3 Inappropriate
2 Incomprehensible
1 Nonverbal
Eye
4 Open spontaneously
3 Open to voice
2 Open to pain
1 No eye opening
Total Score:  3-15
Table 2. Brainstem Reflexes
Pupillary response to light
Corneal reflexes
Caloric responses
Gag reflex
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Organ Donation and Transplantation
Dr. Joseph Murray performed the world’s first transplant 
at Brigham and Women’s Hospital in 1954, and since then 
over 400,000 transplants have been performed.2 In 2007 
there were 21,403 transplants performed in the United States 
(U.S.) alone.3 In medically suitable patients, transplantation 
for end-stage organ failure is the standard of care.4 The most 
commonly needed and transplanted organs, in descending 
order, are the kidney, liver, heart, lung, and pancreas. Kidney 
transplants made up 60% of all transplants in 2007 in the U.S. 
and have been shown to improve quality of life and to be cost-
effective compared to hemodialysis.5 
To comprehend the potential impact of organ donation, 
several statistics are relevant. The five-year survival rates 
for patients on the transplant waiting list compared to those 
that are transplanted are 80.3% vs. 91% for pancreas, 66.5% 
vs. 92% for kidney, and 37.7% vs. 48% for lung. Two-year 
survival rates for heart transplantation wait-listed patients 
range from 44-70%, depending on the severity of heart failure, 
while the five-year survival after heart transplantation is 73%. 
Similarly, the one-year survival rate for patients awaiting liver 
transplantation based on severity ranges from 0-60% and the 
five-year survival after liver transplantation is 73%. It has 
been estimated that an average of 30 life-years are saved per 
organ and tissue donor, based on 2002 statistics, and 55 life-
years would be saved if all organs were maximally utilized.6 
Despite this potential, there are currently 98,161 people on 
the United Network for Organ Sharing (UNOS) waiting 
list3, 77,758 patients went without transplant in 2007, and 
approximately 7,000 died waiting.7
There are several strategies to address the mismatch 
between available and needed organs. Education programs 
increase awareness of transplant needs and thereby increase 
the number of people who choose to donate, while prevention 
efforts lessen the burden of chronic diseases that require a 
transplant. Additionally, UNOS has an extended criteria donor 
program, which matches high-risk patients with advanced age 
or chronic diseases such as Hepatitis with high-risk donors. 
Expanding the donor pool from brain-dead donors to living 
donors and donors after cardiac death also helps to close 
Table 3. Apnea Test Sequence (Derived from reference 9 and 
UCI Declaration of Brain Death Policy and Form - see Figure 2)
1.   Preoxygenate the patient with 100% FiO2
2.   Ensure the patient is not hypocarbic via ABG
3.   Disconnect the ventilator, but supply oropharyngeal oxygen
4.   Monitor the patient for any signs of respiration
5.   Obtain ABGs at selected intervals (q3-4 min)
6.   Stop the test and return to mechanical ventilation if
•   hemodynamic instability occurs, or
•   the patient exhibits attempts to breathe, or 
•   the pCO2 is >60 mmHg or rises > 20 mmHg above 
baseline in the setting of an arterial pH < 7.3
*FiO2 fraction of inspired oxygen; ABG, arterial blood gas; pCO2, partial 
pressure of arterial carbon dioxide
Table 4. Additional Confirmatory Testing for Determination of 
Brain Death
Cerebral angiography
The contrast medium should be injected under high pressure in 
both anterior and posterior circulation.
No intracerebral filling should be detected at the level of entry of 
the carotid or vertebral artery to the skull.
The external carotid circulation should be patent.
The filling of the superior longitudinal sinus may be delayed.
Electroencephalography
A minimum of eight scalp electrodes should be used.
Interelectrode impedances should be between 100 and 10,000 Ω
The integrity of the entire recording system should be tested.
The distance between electrodes should be at least 10 cm.
The sensitivity should be increase to at least 2 µV for 30 
minutes with inclusion of appropriate calibrations.
The high-frequency filter setting should not be set below 30Hz, 
and the low-frequency setting should not be above 1 Hz.
Electroencephalography should demonstrate a lack of reactivity 
to intense somatosensory or audiovisual stimuli.
Transcranial Doppler ultrasonography
There should be bilateral insonation.  The probe should be 
placed at the temporal bone above the zygomatic arch or 
the vertebrobasilar arteries through the suboccipital tran-
scranial window.
The abnormalities should include a lack of diastolic or 
reverberating flow and documentation of small systolic 
peaks in early systole.  A finding of a complete absence of 
flow may not be reliable owing to inadequate transtemporal 
windows for insonation.
Cerebral scintigraphy (technetium Tc 99m hexametazime)
The isotope should be injected within 30 minutes after its 
reconstitution.
A static image of 500,000 counts should be obtained at several 
time points: immediately, between 30 and 60 minutes later, 
and at 2 hours.
A correct intravenous injection may be confirmed with additional 
images of the liver demonstrating uptake (optional).
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CLINICAL ALGORITHM – MANAGEMENT OF ADULT
PATIENTS WITH DEVASTATING BRAIN INJURIES
Penetrating and/or blunt trauma to the brain or 
devastating stroke
Evaluated by Neurosurgery and/or Neurology
Deemed to be non-survivable with no benefits from
neurosurgery intervention
Still requires resuscitation by Trauma/Critical Care
Services-consult to be obtained during course of
treatment
Patient should weigh greater than or equal to 100 lbs
Patient evaluated in ED  or ICU
with devastating brain injury
Initial Steps of Management
ABG/Serum lactate
CBC wdiff, PT/PTT, Electrolytes, Hepatic Function
Panel
Type & Crossmatch 4 PRBC.  Transfuse to maintain
HCT>30, INR <1.4,Platelets >100, fibrinogen > 100
Bolus 1 liter Normal saline
Protect from hypothermia
Central line (large lumen) & arterial line placement
Control active bleeding*
Maintain MAP >70 with fluid bolus
If CVP >8 add Dopamine gtt(@ 5mcg/kg/min) or if
tachyarrythmia develops switch to norepinephrine
drip @ 5 mcg/min-titrate MAP>70
Consider placement of PA catheter
If UOP > 200ml/hr- order serum osmolality  urine
osmolality , and urine specific gravity
Patient MAP >70
Continue maintenance fluids and correct lab 
abnormalities
End points of resuscitation should include
normalization of base deficit, lactate, CVP 6-10
mmHg and/or PAOP 8-15 mmHg, and minimal
use of pressors
Rules of 100's: Goal - SBP> 100mmHg    UOP
>100 ml/hr, Pa02 >100 or FiO2 < 0.3
Maintain fluids; either NS or LR, adjust as
indicated
Continue to fluid resuscitate with 5% Albumin (if
serum albumin <2.0), Blood products (if
indicated) and/or Normal saline until MAP >70
Double dopamine to max 20 mcg/kg/min or 
norephinephrine to max of 20mcg/min q 5
minutes  until MAP > 70
If require 10 mcg/kg/min Dopamine or 10mcg/min
norepinephrine, add vasopressin gtt at 2.4 units/
hour
Yes No
UNIVERSITY of  CALIFORNIA, 
IRVINE
MEDICAL CENTER
CVP  > 10 and/or PAOP (wedge) >17
Continue to bolus with crystalloid/
colloid/blood products if indicated
Lab values and symptoms
suggestive of Diabetes Insipidus:
- UOP > 600ml/hr
- serum sodium > 150 (units)
- urine specific gravity, < 1.005
- Urine osmolality < serum
    osmolality
Yes
No
Start vasopressin at 2.4 units/
hour, and replace UOP >200 ml 
with ½ NS ml for ml every hour
All patient’s require q 4 hour
central or mixed venous
blood gases, ABGs, CMP,
CBC, DIC follow up, serum
lactate, and cardiac output
if available (even after
declaration of brain death
unless care is withdrawn)
Call one Legacy to refer patient
within one hour of being intubated
and having a GCS≤5
CAUTION:
Avoid hypotension and hypoxia in
all head injury patients
Patient can go from hypertension
to hypotension rapidly
Note:  All patients with
devastating brain injury have the
potential to be organ donors.
However, organ donation should
not be discussed with the family
unless directed by the attending
M.D.
Cardiac index <2.5 add Dobutamine
2.5mcg/kg/min and titrate to an index
of 2.5
Cardiac index > 4 add phenylephrine
(20 to 200 mcg/min) or
norepinephrine (1 to 20 mcg/min)
and titrate to a MAP > 70
Cardiac index 2.5 – 4 add
epinephrine (1 to 20 mcg/min) or
norepinephrine titrate to MAP > 70
GOAL
To maintain hemodynamic
stability in patients with
devastating brain injuries
Yes
Consider Social Work and
or Palliative Care team
consultation
Refer to Hormone
Replacement protocol
see next page
ABBREVIATIONS
ABG – arterial blood gases
CBC – complete blood count
CVP – central venous pressure
DI - diabetes insipidous
DIC – disseminated intravascular coagulation
FFP – fresh frozen plasma
gtt – drip
Hb - hemoglobin
HCT – hematocrit
H & H – hematocrit & hemoglobin
HFP- Hepatic function panel
LR- Lactated Ringers
LVH – left ventricle hypertrophy
LVEF – left ventricle ejection fraction
MAP – mean arterial pressure
NS – normal saline
PA – pulmonary artery
PAOP – pulmonary arterial occlusion
pressure
PCWP – pulmonary capillary wedge pressure
SBP – systolic blood pressure
SVR – systemic vascular resistance
UOP – urine output
AUTHORIZED FOR USE
ONLY AT THE UNIVERSITY
OF CALIFORNIA IRVINE
MEDICAL CENTER
D. Malinoski, MD; J. Roum, MD; L. Vu, Pharm D.; T. Bridgeman RN; L. Willis, MHA
Figure 1.  University of California Irvine Medical Center Devastating Brain Injury Pathway
(Included with permission from and only approved for use at UCIMC)
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the gap. Finally, this series of articles focuses on improving 
premortem care of brain-dead donors, which decreases 
the number who succumb to cardiovascular collapse, and 
increases the number and function of viable organs procured 
per donor.10
In the first part of this series, we examine the concept 
and definition of brain death and provide an overview of the 
organ donation process. We will outline the clinician’s role in 
determining brain death and introduce our Devastating Brain 
Injury Algorithm, Figure 1, which is the basis of this series.
BRAIN DEATH
The concept of brain death has caused great controversy 
in medicine and politics. It is debated by ethicists, law 
professors, government agencies and healthcare workers.8-11 
First introduced by Mollaret and Goulon in 1959, brain death 
was originally described as a persistent vegetative state or 
permanent coma.12 After 1959, the definition evolved until 
1968 when a Harvard Medical School ad hoc committee 
created the current definition, which was later affirmed by the 
Uniform Determination of Death Act in 1981.12,13 
In general, brain death is the irreversible loss of all brain 
function. Most agree that complex mental abilities alone do 
not singularly constitute being alive, lest those in a vegetative 
state or with severe cerebral malformations be inappropriately 
declared devoid of life.14 Ultimately, the brainstem controls 
brain function and is responsible for regulating breathing, 
heart rate, and reflexes such as gagging or coughing when 
the airway is obstructed, withdrawal from pain, and pupillary 
function. Without a functioning brainstem, life cannot exist. 
Therefore, diagnosing brain death requires the absence of 
brainstem function. 
To establish a diagnosis of brain death, the clinician must 
first identify the underlying causes and determine that they are 
irreversible.12 Trauma, stroke, cerebral hypoxia, intracranial 
hemorrhage, tumors, meningitis, and encephalitis are all well-
known causes.15 All confounding factors must be eliminated, 
such as hypothermia (< 35°C), hypoxia, intoxication by legal 
or illegal drugs, shock/hypotension, and severe electrolyte 
disturbances.12 Figure 2 shows the brain death declaration 
form and instruction sheet used at our institution. 
The clinical brain death assessment is usually made 
in the intensive care unit (ICU), but if delayed in the 
ED, patients may warrant a brain death exam before 
admission. This evaluation involves three steps: verifying 
unconsciousness, documenting absent brainstem reflexes, 
and performing the apnea test. To verify unconsciousness, a 
Glasgow score of 3 is required (Table 1). The five brainstem 
reflexes that should be assessed in adults are shown in Figure 
3 and Table 2.12 If all brainstem reflexes are absent, an apnea 
test is performed. The patient should have a pCO2 within the 
normal range and be pre-oxygenated with 100% FiO2. The 
apnea test ensures the patient has lost the drive to breathe 
and confirms the diagnosis of brain death. 
 An overview of the procedure and an example of our 
institution’s brain death declaration protocol can be found 
in Table 3 and Figure 2, respectively. Criteria for a positive 
apnea test include: no attempt to breathe while disconnected 
from the ventilator (as oxygen is still delivered to the airway), 
a pCO2 greater than 60mmHg or a rise greater than 20mmHg 
above base-line, and an arterial pH less than 7.3. It usually 
takes 5-10 minutes of apnea for the pCO2 to meet criteria, and 
we recommend drawing blood gasses every three minutes 
until either brain death is confirmed or the patient becomes 
hemodynamically unstable, at which point the patient should 
be reconnected to the ventilator. Some institutions recommend 
that the clinical exam, including the apnea test, be performed 
twice, six hours apart for adults and as much as 48 hours apart 
for neonates, but second assessment remains controversial.9,12
If the patient is hemodynamically unstable and would 
not tolerate even a few minutes off the ventilator for fear 
88090 (Rev. 4/21/08)
Patient Label
BRAIN DEATH DECLARATION FORM
RESULTS
Mechanism consistent with brain death
Other causes of death excluded, for example:
   Toxins / drugs (no contributory abnormalities)
   Metabolic parameters (no contributory abnormalities)
c  Yes   c  No   
Check Box Comments
Response to verbal stimuli absent
Pupils fixed and dilated
Corneal reflex absent
Oculocephalic reflex absent (pt not in C-spine precautions)
Oculovestibular reflex absent (pt in C-spine precautions)
Motor response to noxious stimulation absent
Neurological Examination
c  Yes   c  No  
c  Yes   c  No
c  Yes   c  No  
c  Yes   c  No  
c  Yes   c  No  
c  Yes   c  No
Sucking/rooting reflexes absent (for infants)
For infants Only
c  Yes   c  No   
Temperature (> 35oC) (record:                           )
Blood pressure normal for age (record:                         )
Oxygen saturation (> 90%) (record:                              )
Vital Signs
c  Yes   c No  
c  Yes   c  No    
c  Yes   c  No
4-vessel cerebral angiography
Radionuclide cerebral blood flow study
EEG
Doppler/Ultrasound
Other Confirmatory Tests (as needed)
c  Yes   c  No     
c  Yes   c  No   
c  Yes   c No
c  Yes   c No   
I certify that the above tests have been performed and that according to hospital policy this patient is brain dead.
California Licensed Physician’s Signature License Number
Date Time
Indicate if examination is first or second examination:
If second exam, indicate:  Identity of the first examiner:
  Date and time of the first exam:
Notes: The second page of this form is for information only and does not need to be placed in the medical record.
c  Yes   c  No   
All documentation must indicate the specific date and time of entry and a signature complete with identifying credential, title or classification. 
  pH < 7.30 AND EITHER
  pCO2 > 60 mm Hg OR > 20 mm Hg over baseline  
Apnea Test (no respiratory effort in the setting of):
c  Yes   c No  
c  Yes   c  No
*AFTER ALL CLINICAL CRITERIA ARE MET, EITHER AN APNEA OR OTHER CONFIRMATORY TEST IS 
REQUIRED TO COMPLETE THE FIRST EXAM. THE SECOND EXAM CAN REFER TO THE APNEA OR OTHER 
CONFIRMATORY TEST OF THE FIRST EXAM.
Initial Evaluation
Figure 2.  University of California Irvine Medical Center Brain 
Death Declaration Form and Instruction Sheet (Included with 
permission from and only approved for use at UCIMC)
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of causing cardiopulmonary arrest, other confirmatory 
tests may be used (Table 4). The most common in the U.S. 
is cerebral angiography. If the carotid arteries cut off at 
the base of the skull and there is no blood flow within the 
calvarium, the patient is brain dead. Recently, clinicians 
have used magnetic resonance or computed tomography 
angiograms in lieu of more invasive traditional angiography.16 
Electroencephalography (EEG) is well-validated and 
frequently used to confirm brain death with absent electrical 
activity. The disadvantage of EEG is that devices in the ICU 
may cause artifacts, leading to spurious results.12 Other tests 
include transcranial Doppler ultrasound to assess cerebral 
blood flow and nuclear imaging to assess uptake of tracer in 
the brain. The latter is preferred for secondary confirmation in 
our institution. None of these confirmatory tests replaces the 
clinical exam. 
Since children are more resilient than adults, a longer 
time between assessments has been advocated.12  Additionally, 
many institutions require other confirmatory tests, in addition 
to the apnea test, in children less than one year of age. 
Deciding who is qualified to determine brain death is another 
variable. Some centers advocate that at least two clinicians 
concur on the diagnosis of brain death and that at least one 
of those clinicians be a neurologist or neurosurgeon. Beyond 
these minor differences, the declaration of brain death is 
otherwise similar worldwide.
Once declared brain dead, the patient may become an 
organ donor with family consent or advanced directive. 
This may be verified by living wills or, in some states, by 
registration when obtaining a driver’s license.3  Brain death 
can be a challenging concept for a patient’s family, and 
it is important to equate brain death with the layperson’s 
understanding of bodily death, which usually means that 
the heart has stopped. The essential connection between 
brain function and conscious thought may not be obvious to 
laypersons, and should be stated explicitly. 
It is imperative to separate end-of-life discussions 
surrounding brain death and the withdrawal of medical 
support from conversations about organ donation, to avoid 
any perceived conflict of interest. It is recommended that 
healthcare providers NOT approach family about organ 
donation without first consulting with their local organ 
procurement organization (OPO). In general, representatives 
from the OPO who are formally trained to talk with families 
about organ donation make the first, formal approach after 
end-of-life discussions have taken place. Healthcare providers 
with a close relationship to the family may be involved in the 
process as well. 
Donor Management 
The goal prior to and after the determination of brain 
death is to maintain perfusion of vital organs. This is, at times, 
as much the responsibility of the EP as the intensivist. After 
a family consents to donate organs, the OPO assumes care 
of the donor, both medically and financially, but physician 
involvement is still important to perform procedures and 
provide expert critical care advice. The brain is so central to 
bodily homeostasis, that once dead, it wreaks havoc on all 
other organ systems. Preserving organs is quite challenging in 
the face of brain death, and it is not uncommon to lose donors 
to the spiral of hormonal and cardiovascular collapse.
Recently, studies have proven that aggressive donor 
Figure 3. The Steps in a Clinical Examination to Assess Brainstem Reflexes
The tested cranial nerves are indicated by Roman numerals; the solid arrows represent afferent limbs, and the broken arrows 
efferent limbs. Depicted are the absence of grimacing or eye opening with deep pressure on both condyles at the level of the 
temporomandibular joint (afferent nerve V and efferent nerve VII), the absent corneal reflex elicited by touching the edge of the cornea 
(V and VII), the absent light reflex (II and III), the absent oculovestibular response toward the side of the cold stimulus provided by ice 
water (pen marks at the level of the pupils can be used as reference) (VIII and III and VI), and the absent cough reflex elicited through 
the introduction of a suction catheter deep in the trachea (IX and X). (Adapted from Wijdicks9 and reproduced with permission from 
Mayo Foundation for Medical Education and Research.)
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management (ADM) can improve the quantity and quality of 
donated organs from brain dead donors.4,17-19 After a dedicated 
team of physicians assumed responsibility for the management 
of all potential organ donors at the Los Angeles County / 
University of Southern California Medical Center, there was 
an 82% increase in the number of organ donors and a 71% 
increase in the number of organs recovered.4 Furthermore, 
organizing the care of the brain-dead donor into an evidence-
based clinical protocol has been shown to both decrease 
donors lost to cardiovascular collapse, as well as increase the 
number of organs procured per brain-dead donor.17 
The intensive care of the brain-dead donor does increase 
overall cost of care, but there is no cost to the donor’s estate 
or family.20 The cost-effectiveness of transplantation has been 
well established and has been most extensively reviewed 
for kidney transplantion.3,20-24 Furthermore, it is imperative 
to remember that the care of the donor potentially benefits 
eight patients with end-stage organ failure, and many more 
who will benefit from tissue donation.6, 25 Traditionally, 75% 
of U.S. transplantations have been paid by Medicare.22 The 
transplanted patient or the patient’s insurance company 
pay for the remaining 16% and 9%, respectively.22 Costs 
incurred while caring for the brain-dead donor are ultimately 
distributed amongst the patients receiving the donated organs 
and are usually covered through insurance or Medicare/
Medicaid.26
CONCLUsION
The active participation of all healthcare providers 
involved in the care of patients with severe neurologic insults 
preserves the option of organ donation for patients and their 
families. This care often begins in the ED. Recently, our 
institution implemented a Devastating Brain Injury Pathway 
– an evidence-based protocol designed to improve care of this 
unique population. The primary purposes of the pathway are to 
maintain hemodynamic stability by providing comprehensive 
critical care in order for brain death to be diagnosed, should 
it occur; to give families time to come to the hospital and 
grieve; and to preserve the opportunity of donation for 
patients and their families. It is imperative to explicitly state 
that the primary purpose is not to improve the number of 
organs that can be transplanted, as this would represent a 
potential conflict of interest for the physician caring for the 
injured patient. However, the pathway does represent sound 
neurologic critical care that will improve perfusion to the 
brain and has the potential to turn a devastating brain injury 
into a salvageable one. If a patient does regress to brain death, 
organ perfusion will be maintained should the patient’s family 
decide to donate. In the next two reviews we will discuss the 
pathophysiology of brain death that causes so many donors to 
be lost to cardiovascular collapse (part 2) and the resuscitation 
and management of these donors to preserve the maximum 
amount and function of organs per donor (part 3). 
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